Carl Sandén is a Researcher at Lund University Cancer Centre (LUCC) and an Associate Researcher in the Division of Clinical Genetics and Translational Genomic and Functional Studies of Leukemia at Lund University. His work primarily centers on genomic and molecular studies of leukemia, with a focus on identifying therapeutic vulnerabilities and understanding disease mechanisms. His research interests include Genomics Molecular biology of leukemia Immunology Proteomics Recent publications highlight advances in Single-cell sequencing for leukemia subtypes Targeted therapies (e.g., C3AR inhibitors, IL1RAP targeting) Synthetic lethality in STAG2-mutated AML Immune T-cell dynamics in TP53-mutated AML He contributes to collaborative projects such as Genomic and proteomic analyses of acute leukemia and participates in LUCC-led workshops on AML research.
Dan-Erik Andersson is a Senior Lecturer in Human Rights Studies within the Department of History at Lund University's Faculty of Humanities and Theology. He currently serves as Director of Third Cycle Studies and has previously held the position of Director of Studies for Human Rights Studies from 2003-2009. His academic journey includes doctoral work in ethics with a thesis on global ethics, complemented by a master's degree in political science and qualifications to teach social sciences and religious studies at the high school level. Andersson's research spans human rights, ethics, religion, and Middle East studies, with particular focus on the Middle East community in Sweden. His work examines the intersection of Swedish temperance movement and Middle Eastern immigrants, Swedish football teams with Middle Eastern connections (Assyriska FF, Syrianska FC, Dalkurd, Skånekurd), and Christian communities from Turkey, Iraq and Syria. He has conducted interdisciplinary research on hydrosolidarity in the Nile Basin and currently studies unaccompanied minors in Sweden and their relations to caring institutions. His publication portfolio shows consistent output across multiple formats including academic book chapters, newspaper articles, and edited volumes. Recent work demonstrates engagement with contemporary societal issues such as water governance, social interaction norms during pandemics, and ethical foundations in polarized societies. His research connects with UN Sustainable Development Goals, particularly those related to human rights, reduced inequalities, and peace and justice. Active participant in Lund Human Rights Research Hub Principal investigator for projects on unaccompanied refugee minors Collaborator on multi-disciplinary water governance research Regular contributor to public debate through newspaper articles Andersson's academic activities extend beyond research to include significant contributions to public discourse through lectures, seminars, and media appearances on topics related to human rights, ethics, and religious studies. His work bridges academic research and practical societal challenges, particularly in the areas of migration, integration, and human rights protection.
Camilla Mohlin is a researcher at Linnaeus University , affiliated with the Faculty of Health and Life Sciences and the Department of Chemistry and Biomedical Sciences . Her work primarily focuses on the complement system , age-related macular degeneration (AMD) , and retinal degeneration . Her ongoing research projects include: Advanced Materials for Personalized Medicine & Diagnostics (AMPMeD) Chronic inflammation in AMD patients treated with anti-VEGF injections Complement regulators in AMD pathophysiology Key publication trends span immunology , neuroscience , and nanomedicine , with sub-fields like complement regulation , retinal neuroinflammation , and nanoparticle toxicity . She has published in journals such as: Graefe's Archives for Clinical and Experimental Ophthalmology (2025) Frontiers in Immunology (2023) Journal of Molecular Biology (2023)
Per Nilsson is a senior researcher at Linnaeus University's Department of Chemistry and Biomedical Sciences within the Faculty of Health and Life Sciences. He leads the Host Response to Biomaterials Laboratory (HoRB) and co-leads the Linnaeus University Centre for Biomaterials Chemistry. His work focuses on understanding interactions between the complement system, thromboinflammation, and biomaterials, with applications in transplantation medicine, nanotoxicology, and inflammatory diseases. Research Highlights: Developed novel whole blood models for studying complement activation Created therapeutic coatings to regulate thromboinflammation Investigated complement dysregulation in heart failure and AMD Explored nanoparticle hemocompatibility and blood-material interactions Methodological Expertise: Established advanced analytical techniques for complement proteins Developed quartz crystal microbalance platforms for diagnostics Created experimental models for thromboinflammatory responses Publication Trends (2022-2025): Recent work spans nanotechnology (DNA nanoparticles, iron oxide nanoparticles), cardiovascular immunology (titanium implants, ischemia-reperfusion injury), complement diagnostics, and novel therapeutic approaches targeting C5/CD14 pathways. His research combines molecular biology, materials science, and clinical immunology.
Thomas Hellmark serves as Associate Professor, Senior Lecturer, and Vice Dean at Lund University's Faculty of Medicine. His research focuses on autoimmune diseases, particularly anti-neutrophil cytoplasmic antibody associated vasculitis (AAV), aiming to decipher disease biology and develop novel diagnostics and treatments for conditions causing renal failure and life-threatening complications. His research portfolio spans: Autoimmune disease mechanisms and vasculitis pathogenesis Neutrophil and macrophage dysfunction in inflammation ANCA-associated glomerulonephritis Leukocyte activation and complement pathways Proteomic and genetic screening of immune proteins Analysis of his publication record reveals consistent investigation into cellular abnormalities in AAV, with recent work emphasizing neutrophil phagocytosis defects, macrophage polarization, and T-cell regulation abnormalities using patient-derived samples. Hellmark actively supervises research talent and leads collaborative projects: Formation and Removal of Autoantibodies in Rapidly Progressive Glomerulonephritis (Assistant Supervisor) GOOD-IDES: Anti-GBM glomerulonephritis treatment with bacterial endopeptidase (Co-Investigator) Infect@LU project coordination His work contributes to UN Sustainable Development Goals in health research through international collaborations across Europe and beyond.
Marcus Järås is an Associate Professor and Senior Lecturer at Lund University's Division of Clinical Genetics. He serves as Research Team Manager for Targeted Therapies in Leukemia, Principal Investigator at the Lund University Cancer Centre (LUCC), and Principal Investigator in the StemTherapy National Initiative on Stem Cells for Regenerative Therapy. His academic roles reflect a focus on translational cancer research. Lund University Cancer Centre (LUCC) StemTherapy National Initiative Division of Clinical Genetics Research Interests: Dr. Järås specializes in targeting innate immune checkpoints in acute myeloid leukemia (AML). His work uses CRISPR screens to identify cell surface proteins that protect AML cells from immune attack and evaluates their therapeutic potential through in vivo models. Key areas include leukemia stem cell biology, immune evasion mechanisms, and development of antibody-based immunotherapies. Publication Trends: Recent work explores metabolic vulnerabilities in AML, niche protection of leukemia stem cells, and complement receptor targeting. Earlier studies established the therapeutic value of IL1RAP antibodies, combining CRISPR technology with xenograft models. Leadership & Collaboration: He supervises PhD students, co-organizes LUCC conferences, and chairs sessions at cancer research meetings. Collaborations span multiple institutions including the Swedish Research Council and international networks.
Professor Johan Malm holds multiple academic appointments at Lund University including Professor of Clinical Chemistry (Malmö), Professor of Clinical Protein Science and Imaging, and Professor at EpiHealth: Epidemiology for Health. He serves as Assistant Head of the Department of Translational Medicine and is a Principal Investigator at LUCC: Lund University Cancer Centre. His research focuses on proteomics applications in clinical medicine, with particular emphasis on: Cancer biomarker discovery and validation in melanoma Tissue-specific proteome dynamics and mapping Hormonal regulation of metabolic and immune functions Proteogenomic approaches to cancer heterogeneity Biobanking strategies for precision oncology Recent publications demonstrate strong focus on translational cancer research with articles appearing in high-impact journals including Cancer , Cell , and Cancers . His work integrates proteomics, AI applications, and clinical data to advance cancer diagnostics and therapeutic strategies. Currently leads three major research projects: Complementing clinical decision making of malignant melanoma patients (2024-2027) ReproUnion - Platform for Reproductive Health Innovation (2023-2026) Integrating AI and Spatial Proteomics for Melanoma (2026-2031)
Ashfaque Memon serves as Associate Professor and Senior Lecturer in the Department of Family Medicine and Clinical Epidemiology at Lund University, Sweden, and holds a Principal Investigator position at the Lund University Cancer Centre (LUCC). His academic profile is complemented by an ORCID identifier (0000-0002-1081-3553) and active research leadership. Dr. Memon's research program centers on mitochondrial genetic and epigenetic mechanisms in chronic diseases, with particular focus on diagnostic and prognostic biomarker development. His laboratory within the Center for Primary Health Care Research (CPF) investigates mitochondrial-nuclear genome interactions and dysfunction in conditions including cardiovascular diseases, cancer, type 2 diabetes, and mental disorders. Utilizing clinical samples (serum/plasma, biopsies, whole blood) and large patient databases, his work bridges molecular discoveries with primary care applications. Recent publication trends reveal strong interdisciplinary connections between mitochondrial biology and clinical outcomes across diverse conditions. His 2025-2024 articles demonstrate growing integration of machine learning in cancer prognosis, mitochondrial biomarkers in autoimmune and thrombotic disorders, and metabolic implications of dietary interventions. Scientific recognition includes: Poul Astrup Prize (2006) Postdoctoral fellowship (2010) Postdoctoral fellowship (2007) As an academic supervisor, Dr. Memon has guided four doctoral theses to completion across research areas including mitochondrial roles in cancer diagnosis, oxidative stress in vascular diseases, and genetic biomarkers for thrombosis recurrence. He actively mentors Master's students through the CPF laboratory and maintains five active research projects with substantial grant funding. His collaborative network spans multiple institutions, with recent work involving international partnerships in immunology, oncology, and metabolic research. The CPF experimental research laboratory, under Dr. Memon's leadership, functions as an interdisciplinary hub connecting basic mitochondrial science with clinical applications in primary health care settings, particularly focusing on early disease detection and personalized prevention strategies.
Inger Sigstam serves as a Senior Lecturer in the Department of Mathematics at Uppsala University, holding key administrative roles as director of studies for undergraduate and advanced mathematics programs and course manager for the Basic Course in Mathematics. Education Doctoral degree (FD) Research Focus Her work centers on mathematical logic , specializing in effective mathematics through point-free topology , formal spaces , and domain theory . This research bridges foundational mathematics with theoretical computer science, developing constructive frameworks for topological structures while maintaining rigorous logical formalism. Publication Trends Her output (1995-2004) demonstrates consistent exploration of topological representations using domain theory and formal spaces, complemented by contributions to predicate logic completeness and algebra education. The work reveals strong interdisciplinary connections between logic, topology, and computability theory, with practical applications in mathematical education. Awards and Recognition No scientific awards documented in available sources Academic Leadership As director of studies and course manager, Sigstam shapes curriculum development and student progression pathways. While graduate student supervision isn't explicitly referenced, her educational materials indicate deep engagement with pedagogical innovation at foundational mathematics levels.
Jonathan Leung serves as an Assistant Professor at the Royal Institute of Technology (KTH) in Stockholm, Sweden, where he is affiliated with the School of Engineering Sciences within the Vehicle Engineering department. His primary research focus is in the Rail Vehicles unit, where he develops computational tools to predict material fatigue and damage behavior under extreme conditions. Dr. Leung earned his Ph.D. in Materials Science and Engineering and MSc. in Mechanical Engineering from the Georgia Institute of Technology. His educational background provides the foundation for his expertise in analyzing complex material behaviors under demanding operational environments. His research specializes in understanding and predicting fatigue and damage behavior of engineering materials under extreme conditions and harsh environments. By developing custom computational tools that capture multi-physics mechanisms for damage formation and integrating them into system-level fatigue prediction tools, he increases the ability to predict the influence of various loading, material, and operational factors at multiple length scales. His current work focuses on predicting crack initiation in rails under rolling contact loading by integrating multibody simulations with finite element methods. This research has significant applications in rail transportation, green energy systems, electronic packaging, additive manufacturing, and machinery components. Dr. Leung's research is funded by multiple industry partners including TIMKEN Bearings, Caterpillar, and Magna Industries, as well as government funding agencies. His work bridges theoretical modeling with practical engineering applications, particularly in improving the accuracy of rolling contact fatigue crack initiation prediction and elucidating microstructural damage mechanisms that cause subsurface microstructural transformations in high-strength steels. As an educator, Dr. Leung serves as examiner for the Degree project in rail vehicle technology (advanced level, SD231X) and teaches Rail Vehicle Dynamics (SD2313) and Rail Vehicle Technology (SD2307). His teaching directly complements his research expertise in vehicle engineering with particular emphasis on rail systems.
Professor Gunnar Nilsson is a distinguished academic at Karolinska Institutet, holding the title of Professor of Family Medicine with a special focus on Medical Informatics within the Department of Neurobiology, Care Sciences and Society. His roles include teaching, research leadership, and contributions to healthcare policy. He has held positions such as Pro-Dean of Higher Education and Head of the Division of Family Medicine. His research spans medical informatics, healthcare management, and pedagogy, with over 100 publications and extensive supervisory experience. Education: Gunnar Nilsson earned a Licentiate Degree (2002) and a Doctor of Philosophy (2002) from the Department of Clinical Science, Intervention and Technology at Karolinska Institutet. His academic journey is complemented by clinical experience as a general practitioner over 27 years across multiple specialties. Research Interests: Medical informatics, person-centered healthcare, primary care optimization, health economics, and medical education. His work emphasizes leveraging information technology to improve healthcare efficiency and patient outcomes. Article Trends: Recent research focuses on healthcare utilization in geriatric populations, telemedicine applications, stroke prevention, and medical education innovations. His studies often bridge clinical practice, policy, and technology. Awards: Recipient of the 2013 Pedagogic Prize and 2023 Silver Medal from Karolinska Institutet, recognizing his contributions to medical education and research. Grants & Leadership: Leads projects funded by the Swedish Research Council, focusing on care coordination, stroke prevention, and educational initiatives. Supervised 18 doctoral candidates and supported 4 pedagogic doctoral programs. Active in strategic committees and international collaborations (e.g., STINT-funded sabbatical in Singapore). Teams & Affiliations: Affiliated with the Centre of Family Medicine (CeFAM) and involved in interdisciplinary teams addressing healthcare policy, medical informatics, and pedagogical advancements.
Prof. Jorma Hinkula is a Professor of Molecular Virology at Linköping University's Department of Biomedical and Clinical Sciences (BKV), under the Division of Molecular Medicine and Virology. He leads research into vaccines and antiviral therapies targeting HIV-1, influenza, rotaviruses, and Crimean-Congo hemorrhagic fever. His work integrates virology, immunology, and nanotechnology to develop innovative biomedical solutions. Education: PhD in Medical Sciences (1993) Bachelor of Science in Biomedical Laboratory Sciences (1989) Research Interests: His lab focuses on: Vaccine design using nanotechnology and virus-like particles Host-virus interactions, particularly complement opsonization effects on immune cells Pre-clinical evaluation of nanovaccines in collaboration with University College London Recent Article Trends: His 2024 work explores lipid-based adjuvants and coacervate nanostructures for vaccines, while 2023 studies highlight sex-specific immune responses in diabetic populations. Earlier 2022 research includes antiviral peptides against SARS-CoV-2 and flaviviruses. Advising & Grants: He supervises postdoctoral fellows in the MIIC Program and manages BSL3 laboratory operations. His team collaborates globally on vaccine development and 3D tissue culture models. Labs/Teams: The Division of Molecular Medicine and Virology (MMV) supports his interdisciplinary research, combining basic science with clinical translation.
Göran Engberg is a Professor at the Department of Physiology and Pharmacology at Karolinska Institutet. He leads the Electrophysiological Neuropharmacology research group, focusing on neuropharmacological mechanisms underlying neuropsychiatric disorders. His work centers on kynurenic acid’s role in schizophrenia pathogenesis, particularly its interaction with glutamate receptors and immune system activation. His research integrates electrophysiology, molecular biology, and translational studies to explore how immune-mediated kynurenine pathway dysregulation contributes to psychosis. Collaborations include SciLifeLab for drug development targeting kynurenic acid levels. Engberg’s lab also investigates neurodevelopmental models, such as social isolation effects on rodent sensorimotor gating, linking immune activation to schizophrenia-like behaviors. Key projects examine CSF biomarkers (e.g., neurogranin, complement proteins) in psychosis, cytokine signaling pathways, and genetic influences on kynurenine metabolism. Engberg’s studies highlight interdisciplinary approaches, combining preclinical models with clinical data from first-episode psychosis cohorts. His lab’s facilities include electrophysiological setups, microdialysis systems, and advanced proteomic/metabolomic analyses. Engberg maintains active roles in academic leadership, contributing to departmental strategic planning and training early-career researchers in neuropharmacology and translational neuroscience.
Sophie Erhardt is a Professor and Head of the Department of Physiology and Pharmacology (FyFa) at Karolinska Institutet. Her research focuses on neuropsychoimmunology, particularly the kynurenine pathway's role in psychiatric disorders like schizophrenia and bipolar disorder. She leads a research group exploring immune-brain interactions and develops novel treatments for neuropsychiatric conditions. Dr. Erhardt holds leadership roles in organizations including the Scandinavian College of Neuropsychopharmacology and the International Society of Tryptophan Research. She earned a PhD in Pharmacology from Karolinska Institutet (2001) and completed postdoctoral training at UC San Diego. Her work has yielded over 140 publications and 16 doctoral student supervisions. Key achievements include identifying KAT III as a critical enzyme in KYNA synthesis and discovering biomarkers like picolinic acid for suicide risk prediction. Her research integrates experimental neuroscience, clinical psychiatry, and drug development, aiming to bridge basic science and precision medicine. Notable awards include the 2022 Maltz Prize and 2023 Arvid Carlsson Award. She collaborates internationally, including with Mayo Clinic and SciLifeLab's Drug Discovery platform. Dr. Erhardt teaches pharmacology at undergraduate and graduate levels, coordinating courses like the Single Subject Course in Pharmacology. She focuses on neuropsychopharmacology, cardiovascular pharmacology, and immune system pharmacology, emphasizing curriculum development and student evaluations.
Christian G. Giske is a Professor of Clinical Bacteriology at Karolinska Institutet, part of the Department of Laboratory Medicine. He also serves as a Senior Physician at Karolinska University Hospital. His research focuses on antimicrobial resistance (AMR) in pathogens such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with translational studies on bacteriophage therapy and microbiome interactions. Dr. Giske completed his medical training at the Norwegian University of Science and Technology (2000), earned his PhD at Karolinset (2007), and became a Professor in 2018. Education: MD: Norwegian University of Science and Technology, 2000 PhD: Karolinska Institutet, 2007 Specialist in Clinical Microbiology, 2007 Associate Professor, 2010 Research Interests: His work spans AMR mechanisms, clonal spread of resistant strains, and therapeutic innovations like phage therapy. Key themes include: Epidemiology of drug-resistant Gram-negative bacilli Microbiome impacts of antibiotics Bacteriophage-based treatments Grants & Collaborations: Active in multiple projects funded by the Swedish Research Council and international bodies, including studies on phage-antimicrobial combinations, Pseudomonas infections in cystic fibrosis, and global AMR surveillance. He leads a research group with 15+ affiliated members. Labs/Teams: Directs the Antimicrobial Resistance research group at Karolinska, collaborating internationally on projects like the PILGRIM EU initiative studying AMR in gut microbiota.
